NCT04117906

Brief Summary

This study pilots a novel, brief, online, self-help training course for anxiety management, aimed at adults experiencing moderate to moderately-severe anxiety.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
77

participants targeted

Target at P25-P50 for not_applicable anxiety

Timeline
Completed

Started Nov 2019

Shorter than P25 for not_applicable anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 4, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 7, 2019

Completed
26 days until next milestone

Study Start

First participant enrolled

November 2, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 10, 2020

Completed
Last Updated

August 20, 2020

Status Verified

October 1, 2019

Enrollment Period

2 months

First QC Date

October 4, 2019

Last Update Submit

August 19, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change from baseline (week 0) at post-intervention (week 3) on the Generalised Anxiety Disorder 7 (GAD-7) scale.

    The Generalised Anxiety Disorder 7 (GAD-7) scale is a self-report measure of general anxiety, producing a total score between 0 and 21, with higher scores indicating greater levels of general anxiety.

    Post-intervention (3 weeks after baseline).

Secondary Outcomes (9)

  • Change from baseline (week 0) at follow-up (week 5) on the Generalised Anxiety Disorder 7 (GAD-7) scale.

    Follow-up (5 weeks after baseline).

  • Change from baseline (week 0) at post-intervention (week 3) on the Patient Health Questionnaire 9 (PHQ-9).

    Post-intervention (3 weeks after baseline).

  • Change from baseline (week 0) at follow-up (week 5) on the Patient Health Questionnaire 9 (PHQ-9).

    Follow-up (5 weeks after baseline).

  • Change from baseline (week 0) at post-intervention (week 3) on the Warwick-Edinburgh Mental Well-Being Scale (WEMWBS).

    Post-intervention (3 weeks after baseline).

  • Change from baseline (week 0) at follow-up (week 5) on the Warwick-Edinburgh Mental Well-Being Scale (WEMWBS).

    Follow-up (5 weeks after baseline).

  • +4 more secondary outcomes

Study Arms (2)

STAGE course

EXPERIMENTAL
Behavioral: STAGE training for anxiety

Wait-list control

NO INTERVENTION

The wait-list control group will receive access to the STAGE course after the trial is complete.

Interventions

STAGE is a brief, online, self-help course designed to target anxiety through providing training in perspective broadening and self-distancing.

STAGE course

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • having a score, at baseline, on the Generalised Anxiety Disorder 7 (GAD-7) scale of between 8 and 15, inclusive;
  • having regular internet access;
  • being based in the UK.

You may not qualify if:

  • significant risk issues in the last year;
  • currently receiving another psychological intervention, whether it be self-help or face-to-face;
  • having recently (within the last six months) completed a psychological intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Canterbury Christ Church University

Royal Tunbridge Wells, Kent, TN1 2YG, United Kingdom

Location

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Asuka Boyle, MSc

    Canterbury Christ Church University

    PRINCIPAL INVESTIGATOR
  • Fergal Jones, PhD, PsychD

    Canterbury Christ Church University

    STUDY DIRECTOR
  • Emma Travers-Hill, PhD, PsychD

    Kent and Medway NHS and Social Care Partnership Trust

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Measures will be completed online without direct involvement from the research team.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 4, 2019

First Posted

October 7, 2019

Study Start

November 2, 2019

Primary Completion

January 10, 2020

Study Completion

January 10, 2020

Last Updated

August 20, 2020

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations